Liso-cel Approved by FDA as Breyanzi
Here is a brief preview of this blast: Late today, BMS announced US approval of liso-cel in r/r LBCL after >2L of systemic therapy. The press release states that the target turnaround time is 24 days from its manufacturing facility in Bothell, Washington, USA. The Celltelligence team will be conducting a full thoughts-on label review in the coming days (link to Breyanzi PI here).